What is Mettler-Toledo International's earnings per share (EPS)?

Mettler-Toledo International (MTD) reported diluted earnings per share of $42.05 for fiscal year 2025. This represents a 3.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Mettler-Toledo International (MTD) Financials

MTD NYSE

Trailing 12 months to June 30, 2026

Revenue $4.1B +6.9% YoY

Net Income $905.6M +9.1% YoY

EPS (Diluted) $44.38 +12.5% YoY

Free Cash Flow $864.0M +1.9% YoY

Market Cap $33.5B as of Oct 26, 2026

Price / Sales 8.1x on $4.1B revenue, trailing 12 months to June 30, 2026

Price / Earnings 36.9x on $905.6M net income, trailing 12 months to June 30, 2026

Price / Book n/m outside the range published as a multiple, on $12.8M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 26, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 31, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 31, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MTD SEC filings page.

Mettler-Toledo International (MTD) reported $4.1B in revenue over the twelve months to Jun 30, 2026, up 6.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MTD FY2025 2026-10-24

Mettler-Toledo produces substantial cash, but FY2025 shows expansion and financing growing faster than earnings.

Operating cash flow of $955.8M exceeded net income of $869.2M, so reported earnings were backed by cash rather than being mainly accruals. Yet free cash flow was $848.6M after $107.1M of capital expenditures, revealing an ongoing reinvestment claim on that cash.

Revenue grew 4.0%, but net income grew only 0.7%, indicating that additional sales translated into little incremental profit in FY2025. SG&A rose faster than sales, increasing 6.6% against revenue growth of 4.0%, so expense growth absorbed much of the added revenue.

Liabilities exceeded assets at 100.6%, leaving equity at -$23.6M; the balance sheet is financed almost entirely by obligations rather than shareholder capital. The current ratio was 1.1x while long-term debt increased 14.0%, pointing to greater reliance on longer-duration financing than on near-term liabilities.

Financial Health Signals

Financial Health Score 59/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Mettler-Toledo International's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Growth

Mettler-Toledo International's revenue grew a modest 4.0% year-over-year to $4.0B. This slow but positive growth earns a score of 42/100.

Leverage

Liquidity

Mettler-Toledo International's current ratio of 1.14 is below the typical benchmark, resulting in a score of 26/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Mettler-Toledo International converts 21.1% of revenue into free cash flow ($848.6M). This strong cash generation earns a score of 88/100.

Returns

Piotroski F-Score Neutral

6/9

Mettler-Toledo International passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, all 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.10x

For every $1 of reported earnings, Mettler-Toledo International generates $1.10 in operating cash flow ($955.8M OCF vs $869.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.0B

YoY+4.5%

QoQ+8.5%

5Y CAGR+2.1%

10Y CAGR+5.4%

Mettler-Toledo International generated $1.0B in revenue in Q2 2026. This represents an increase of 4.5% from the same quarter a year earlier. Against the prior quarter it is up 8.5%.

Net Income

$232.9M

YoY+15.1%

QoQ+37.4%

5Y CAGR+4.7%

10Y CAGR+11.3%

Mettler-Toledo International reported $232.9M in net income in Q2 2026. This represents an increase of 15.1% from the same quarter a year earlier. Against the prior quarter it is up 37.4%.

EPS (Diluted)

$11.55

YoY+18.3%

QoQ+38.7%

5Y CAGR+8.0%

10Y CAGR+14.7%

Mettler-Toledo International earned $11.55 per diluted share (EPS) in Q2 2026. This represents an increase of 18.3% from the same quarter a year earlier. Against the prior quarter it is up 38.7%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow

$282.6M

YoY+33.0%

QoQ+130.9%

5Y CAGR+4.9%

10Y CAGR+10.3%

Mettler-Toledo International generated $282.6M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 33.0% from the same quarter a year earlier. Against the prior quarter it is up 130.9%.

Cash & Debt

$51.4M

YoY-16.9%

QoQ-15.2%

5Y CAGR-18.4%

10Y CAGR-7.7%

Mettler-Toledo International held $51.4M in cash against $2.0B in long-term debt as of Q2 2026.

Shares Outstanding

20M

YoY-2.7%

QoQ-0.8%

5Y CAGR-2.8%

10Y CAGR-2.8%

Mettler-Toledo International had 20M shares outstanding in Q2 2026. This represents a decrease of 2.7% from the same quarter a year earlier. Against the prior quarter it is down 0.8%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

63.3%

YoY+4.3pp

QoQ+4.6pp

5Y change+5.2pp

10Y change+6.2pp

Mettler-Toledo International's gross margin was 63.3% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 4.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.6 percentage points.

Net Margin

22.7%

YoY+2.1pp

QoQ+4.8pp

5Y change+2.7pp

10Y change+9.6pp

Mettler-Toledo International's net profit margin was 22.7% in Q2 2026, showing the share of revenue converted to profit. This is up 2.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.8 percentage points.

Return on Equity

1816.3%

Mettler-Toledo International's quarterly ROE was 1816.3% in Q2 2026: one quarter's net income over shareholder equity, not annualized.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

R&D Spending

$53.0M

YoY+7.5%

QoQ+3.3%

5Y CAGR+4.5%

Mettler-Toledo International invested $53.0M in research and development in Q2 2026. This represents an increase of 7.5% from the same quarter a year earlier. Against the prior quarter it is up 3.3%.

Share Buybacks

$206.3M

YoY-5.7%

QoQ0.0%

5Y CAGR-0.6%

10Y CAGR+5.1%

Mettler-Toledo International spent $206.3M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 5.7% from the same quarter a year earlier. It is unchanged from the prior quarter.

Capital Expenditures

$27.8M

YoY+16.4%

QoQ+59.6%

5Y CAGR+4.1%

10Y CAGR+6.7%

Mettler-Toledo International invested $27.8M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 16.4% from the same quarter a year earlier. Against the prior quarter it is up 59.6%.

MTD Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MTD quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$4.1B	$4.0B+4.0%	$3.9B+2.2%	$3.8B-3.4%	$3.9B+5.4%	$3.7B+20.5%	$3.1B+2.5%	$3.0B+2.5%	$2.9B+7.7%	$2.7B+8.6%	$2.5B+4.7%	$2.4B-3.6%	$2.5B+4.5%	$2.4B+1.6%	$2.3B+1.4%	$2.3B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$833.8M+8.6%	$767.8M+3.1%	$744.9M-8.1%	$810.5M+1.9%	$795.2M-2.0%	$811.2M+1.6%	$798.7M
Gross Profit	$2.5B	$2.4B+2.8%	$2.3B+3.8%	$2.2B-2.9%	$2.3B+6.3%	$2.2B+20.6%	$1.8B+3.4%	$1.7B+3.4%	$1.7B+6.9%	$1.6B+9.6%	$1.4B+6.3%	$1.4B-0.5%	$1.4B+6.0%	$1.3B+3.3%	$1.2B+1.9%	$1.2B
R&D Expenses	$208.0M	$199.4M+5.3%	$189.4M+2.2%	$185.3M+4.6%	$177.1M+4.3%	$169.8M+21.2%	$140.1M-2.7%	$143.9M+2.0%	$141.1M+9.9%	$128.3M+7.6%	$119.2M+0.1%	$119.1M-3.4%	$123.3M+6.0%	$116.3M+3.4%	$112.5M-3.1%	$116.1M
SG&A Expenses	$1.0B	$998.3M+6.6%	$936.3M+3.6%	$904.1M-3.7%	$938.5M-0.6%	$944.0M+15.1%	$820.2M+0.1%	$819.2M+0.8%	$812.8M+2.3%	$794.9M+6.6%	$745.4M+6.4%	$700.8M-3.8%	$728.6M+5.2%	$692.7M+1.3%	$684.0M-2.8%	$703.6M
Interest Expense	$69.3M	$68.5M-8.2%	$74.6M-3.5%	$77.4M+39.7%	$55.4M+28.1%	$43.2M+12.0%	$38.6M+3.2%	$37.4M+8.4%	$34.5M+5.3%	$32.8M+17.0%	$28.0M+2.1%	$27.5M+11.9%	$24.5M+8.0%	$22.7M-0.2%	$22.8M-2.0%	$23.2M
Income Tax	$191.8M	$179.7M+3.2%	$174.1M-5.9%	$184.9M-6.6%	$198.1M+9.8%	$180.4M+23.5%	$146.0M+21.4%	$120.3M-13.6%	$139.2M-29.8%	$198.3M+65.5%	$119.8M+8.3%	$110.6M+3.6%	$106.8M+10.5%	$96.6M+5.3%	$91.8M+15.1%	$79.7M
Net Income	$905.6M	$869.2M+0.7%	$863.1M+9.4%	$788.8M-9.6%	$872.5M+13.5%	$769.0M+27.6%	$602.7M+7.4%	$561.1M+9.5%	$512.6M+36.3%	$376.0M-2.2%	$384.4M+8.9%	$352.8M+4.3%	$338.2M+10.5%	$306.1M+5.2%	$290.8M+7.9%	$269.5M
EPS (Basic)	N/A	$42.17+3.7%	$40.67+12.7%	$36.10-6.9%	$38.79+16.7%	$33.25+31.7%	$25.24+10.5%	$22.84+12.3%	$20.33+39.1%	$14.62+0.9%	$14.49+13.6%	$12.75+8.9%	$11.71+14.6%	$10.22+9.1%	$9.37+10.9%	$8.45
EPS (Diluted)	$44.38	$42.05+3.9%	$40.48+12.8%	$35.90-6.5%	$38.41+17.2%	$32.78+31.6%	$24.91+10.9%	$22.47+13.0%	$19.88+39.6%	$14.24+0.1%	$14.22+13.9%	$12.48+9.1%	$11.44+14.9%	$9.96+9.0%	$9.14+11.3%	$8.21
Diluted Shares (Avg)	N/A	21M-3.0%	21M-3.0%	22M-3.3%	23M-3.2%	23M-3.1%	24M-3.1%	25M-3.1%	26M-2.3%	26M-2.3%	27M-4.4%	28M-4.4%	30M-3.8%	31M-3.4%	32M-3.1%	33M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$1.0B+4.5%	$947.1M+7.2%	$1.1B+8.1%	$1.0B+7.9%	$983.2M+3.9%	$883.7M-4.6%	$1.0B+11.8%	$954.5M+1.3%
Gross Profit	$650.2M+12.1%	$555.8M+5.7%	$675.4M+5.6%	$609.5M+6.5%	$579.9M+2.5%	$525.9M-4.1%	$639.3M+15.9%	$572.5M+2.3%
R&D Expenses	$53.0M+7.5%	$51.3M+10.6%	$52.6M+5.1%	$51.1M+8.5%	$49.3M+7.7%	$46.3M-0.1%	$50.1M+7.8%	$47.1M+2.1%
SG&A Expenses	$263.3M+6.5%	$258.3M+6.4%	$259.8M+9.5%	$248.4M+8.6%	$247.3M+4.9%	$242.8M+3.6%	$237.3M+6.2%	$228.8M+5.2%
Interest Expense	$17.2M+2.8%	$17.0M+2.1%	$17.4M-2.6%	$17.7M-4.9%	$16.8M-11.5%	$16.7M-13.4%	$17.9M-9.2%	$18.6M-8.3%
Income Tax	$56.5M+22.0%	$40.2M+4.8%	$43.3M-30.4%	$51.7M+9.1%	$46.3M+116.8%	$38.4M-10.9%	$62.2M+30.3%	$47.4M-4.2%
Net Income	$232.9M+15.1%	$169.5M+3.6%	$285.8M+13.3%	$217.5M+2.8%	$202.3M-8.8%	$163.6M-7.8%	$252.3M+36.5%	$211.5M+4.9%
EPS (Basic)	$11.57+18.3%	$8.35+6.5%	$13.97+16.6%	$10.60+5.9%	$9.78-6.1%	$7.84-5.3%	$11.98+40.0%	$10.01+8.1%
EPS (Diluted)	$11.55+18.3%	$8.33+6.7%	$13.93+16.8%	$10.57+6.1%	$9.76-5.9%	$7.81-5.2%	$11.93+39.9%	$9.96+8.1%
Diluted Shares (Avg)	20M-2.8%	20M-2.9%	N/A	21M-3.2%	21M-3.1%	21M-2.8%	N/A	21M-2.9%

Not reported in any period shown, so not listed: Cost of Revenue, Operating Income, EBITDA.

MTD Balance Sheet

MTD quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$3.7B+14.6%	$3.2B-3.4%	$3.4B-3.9%	$3.5B+5.0%	$3.3B+18.2%	$2.8B+0.9%	$2.8B+6.5%	$2.6B+2.7%	$2.5B+17.7%	$2.2B+10.6%	$2.0B-0.7%	$2.0B-8.3%	$2.2B+6.5%	$2.0B-4.4%	$2.1B
Current Assets	$1.4B+14.1%	$1.2B-3.0%	$1.2B-10.5%	$1.4B+8.3%	$1.3B+20.1%	$1.1B-4.8%	$1.1B+6.1%	$1.0B+3.9%	$1.0B+12.3%	$896.8M+12.8%	$795.3M-6.4%	$849.4M-7.1%	$914.0M+5.8%	$864.2M-15.2%	$1.0B
Cash & Equivalents	$66.9M+12.7%	$59.4M-15.0%	$69.8M-27.3%	$96.0M-2.6%	$98.6M+4.6%	$94.3M-54.6%	$207.8M+16.7%	$178.1M+19.8%	$148.7M-6.3%	$158.7M+60.5%	$98.9M+16.0%	$85.3M-23.8%	$111.9M+10.0%	$101.7M-56.8%	$235.6M
Short-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Inventory	$387.2M+13.1%	$342.3M-11.3%	$385.9M-12.6%	$441.7M+6.5%	$414.5M+39.3%	$297.6M+8.5%	$274.3M+2.0%	$268.8M+5.3%	$255.4M+15.0%	$222.0M+3.6%	$214.4M+4.8%	$204.5M-2.8%	$210.4M+5.8%	$198.9M-17.6%	$241.4M
Accounts Receivable	$778.2M+13.3%	$687.1M+3.5%	$663.9M-6.4%	$709.3M+9.6%	$647.3M+9.0%	$593.8M+4.9%	$566.3M+5.7%	$535.5M+1.3%	$528.6M+16.2%	$455.0M+10.6%	$411.4M-5.6%	$435.6M-6.7%	$466.7M+6.7%	$437.4M+2.9%	$425.1M
Long-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Goodwill	$739.2M+10.5%	$668.9M-0.2%	$670.1M+1.5%	$660.2M+1.8%	$648.6M+17.9%	$550.3M+2.7%	$536.0M+0.2%	$534.8M-0.9%	$539.8M+13.3%	$476.4M+6.7%	$446.3M+0.5%	$444.1M-2.6%	$455.8M+0.8%	$452.4M+1.0%	$447.7M
Total Liabilities	$3.7B+11.0%	$3.4B-4.0%	$3.5B+1.1%	$3.5B+9.9%	$3.2B+24.6%	$2.5B+6.9%	$2.4B+16.7%	$2.0B+1.3%	$2.0B+15.6%	$1.7B+25.6%	$1.4B+6.9%	$1.3B+5.9%	$1.2B+1.9%	$1.2B-16.0%	$1.4B
Current Liabilities	$1.2B+2.6%	$1.2B-1.1%	$1.2B+2.9%	$1.1B+0.1%	$1.1B+36.4%	$840.3M+11.4%	$754.5M+2.7%	$734.4M+6.5%	$689.7M+17.4%	$587.5M+5.2%	$558.2M-17.8%	$678.9M+20.3%	$564.2M+0.4%	$562.0M-7.8%	$609.8M
Non-Current Liabilities	$2.5B+15.4%	$2.2B-5.4%	$2.3B+0.2%	$2.3B+15.5%	$2.0B+18.8%	$1.7B+4.8%	$1.6B+24.7%	$1.3B-1.4%	$1.3B+14.7%	$1.1B+39.4%	$820.7M+34.4%	$610.6M-6.6%	$653.6M+3.2%	$633.1M-22.1%	$812.5M
Long-Term Debt	$2.1B+14.0%	$1.8B-3.0%	$1.9B-1.0%	$1.9B+20.7%	$1.6B+23.1%	$1.3B+4.0%	$1.2B+25.4%	$985.0M+2.6%	$960.2M+9.7%	$875.1M+52.1%	$575.1M+71.3%	$335.8M-15.2%	$396.0M+14.1%	$347.1M-27.2%	$476.7M
Total Equity	-$23.6Mn/m	-$126.9Mn/m	-$149.9M-704.8%	$24.8M-85.5%	$171.4M-39.4%	$282.7M-32.8%	$420.8M-28.7%	$590.1M+7.8%	$547.3M+25.8%	$434.9M-25.1%	$580.5M-19.3%	$719.6M-23.0%	$935.1M+13.0%	$827.2M+5.9%	$781.1M
Retained Earnings	$9.2B+10.4%	$8.4B+11.5%	$7.5B+11.7%	$6.7B+14.8%	$5.9B+15.0%	$5.1B+13.3%	$4.5B+14.1%	$3.9B+14.8%	$3.4B+12.0%	$3.1B+13.9%	$2.7B+14.2%	$2.4B+15.7%	$2.0B+16.5%	$1.7B+18.5%	$1.5B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$3.7B+8.0%	$3.7B+13.4%	$3.7B+14.6%	$3.5B+6.1%	$3.4B+4.7%	$3.2B-1.5%	$3.2B-3.4%	$3.3B+0.9%
Current Assets	$1.3B+8.3%	$1.3B+14.3%	$1.4B+14.1%	$1.3B+6.9%	$1.2B+5.6%	$1.2B-3.8%	$1.2B-3.0%	$1.2B+0.1%
Cash & Equivalents	$51.4M-16.9%	$60.6M-5.8%	$66.9M+12.7%	$69.1M-3.5%	$61.8M-12.7%	$64.3M-8.4%	$59.4M-15.0%	$71.6M+2.7%
Short-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m
Inventory	$411.6M+6.1%	$404.8M+12.8%	$387.2M+13.1%	$401.8M+6.9%	$388.1M+5.9%	$358.8M-4.0%	$342.3M-11.3%	$375.8M0.0%
Accounts Receivable	$731.5M+7.3%	$708.2M+10.9%	$778.2M+13.3%	$687.3M+7.9%	$681.6M+7.4%	$638.4M-1.8%	$687.1M+3.5%	$637.2M+0.4%
Long-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m
Goodwill	$735.2M+7.5%	$736.9M+9.5%	$739.2M+10.5%	$731.2M+8.7%	$684.1M+2.8%	$673.2M+1.1%	$668.9M-0.2%	$672.4M+1.8%
Total Liabilities	$3.7B0.0%	$3.7B+8.6%	$3.7B+11.0%	$3.8B+8.5%	$3.7B+7.6%	$3.4B-0.7%	$3.4B-4.0%	$3.5B+2.3%
Current Liabilities	$1.2B+8.5%	$1.1B-3.6%	$1.2B+2.6%	$1.2B+0.6%	$1.1B-13.6%	$1.1B+1.6%	$1.2B-1.1%	$1.2B+10.7%
Non-Current Liabilities	$2.5B-3.7%	$2.6B+14.8%	$2.5B+15.4%	$2.6B+12.6%	$2.6B+20.4%	$2.3B-1.9%	$2.2B-5.4%	$2.3B-1.5%
Long-Term Debt	$2.0B-3.7%	$2.2B+14.3%	$2.1B+14.0%	$2.1B+13.5%	$2.1B+21.6%	$1.9B-0.6%	$1.8B-3.0%	$1.9B-2.0%
Total Equity	$12.8Mn/m	-$41.9Mn/m	-$23.6Mn/m	-$249.2Mn/m	-$258.8Mn/m	-$182.0Mn/m	-$126.9Mn/m	-$154.4Mn/m
Retained Earnings	$9.6B+10.3%	$9.4B+10.2%	$9.2B+10.4%	$9.0B+10.3%	$8.7B+10.5%	$8.5B+11.0%	$8.4B+11.5%	$8.1B+10.8%

MTD Cash Flow Statement

MTD quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$975.2M	$955.8M-1.3%	$968.3M+0.3%	$965.9M+12.4%	$859.1M-5.5%	$908.8M+25.4%	$724.7M+20.1%	$603.5M+6.8%	$565.0M+9.4%	$516.3M+12.1%	$460.8M+4.8%	$439.8M+5.0%	$418.9M+21.1%	$345.9M+5.6%	$327.7M+16.7%	$280.9M
Depreciation & Amortization	N/A	$81.4M+4.1%	$78.2M+1.5%	$77.1M+5.2%	$73.3M+8.6%	$67.5M+16.9%	$57.7M+6.8%	$54.1M+5.1%	$51.5M+14.5%	$45.0M+9.5%	$41.0M+4.2%	$39.4M-1.8%	$40.1M-1.3%	$40.7M+0.1%	$40.6M+5.5%	$38.5M
Stock-Based Compensation	N/A	$22.5M+12.7%	$20.0M+11.4%	$17.9M-8.8%	$19.7M+0.3%	$19.6M+4.9%	$18.7M+2.2%	$18.3M+4.0%	$17.6M+6.0%	$16.6M+8.3%	$15.3M+7.6%	$14.2M+4.5%	$13.6M+7.7%	$12.6M-4.1%	$13.2M+7.5%	$12.3M
Capital Expenditures	$111.2M	$107.1M+3.1%	$103.9M-1.4%	$105.3M-13.1%	$121.2M+12.7%	$107.6M+16.3%	$92.5M-5.0%	$97.3M-31.8%	$142.7M+12.0%	$127.4M+2.8%	$124.0M+50.2%	$82.5M-7.7%	$89.4M+8.5%	$82.3M-13.9%	$95.6M-3.0%	$98.5M
Free Cash Flow	$864.0M	$848.6M-1.8%	$864.4M+0.5%	$860.6M+16.6%	$737.8M-7.9%	$801.2M+26.7%	$632.2M+24.9%	$506.1M+19.9%	$422.3M+8.6%	$388.9M+15.5%	$336.8M-5.7%	$357.3M+8.4%	$329.5M+25.0%	$263.6M+13.6%	$232.1M+27.3%	$182.4M
Investing Cash Flow	-$172.6M	-$193.9Mn/m	-$119.5Mn/m	-$131.7Mn/m	-$139.4Mn/m	-$314.1Mn/m	-$100.4Mn/m	-$99.1Mn/m	-$138.9Mn/m	-$217.3Mn/m	-$231.5Mn/m	-$100.8Mn/m	-$94.3Mn/m	-$86.0Mn/m	-$97.3Mn/m	-$132.3M
Financing Cash Flow	-$817.1M	-$755.2Mn/m	-$856.0Mn/m	-$859.6Mn/m	-$716.0Mn/m	-$590.5Mn/m	-$743.9Mn/m	-$477.4Mn/m	-$388.0Mn/m	-$319.5Mn/m	-$163.6Mn/m	-$320.0Mn/m	-$348.2Mn/m	-$249.9Mn/m	-$366.4Mn/m	-$360.5M
Share Buybacks	$775.0M	$800.0M-5.9%	$850.0M-5.6%	$900.0M-18.2%	$1.1B+10.0%	$1000.0M+29.0%	$775.0M0.0%	$775.0M+63.2%	$475.0M+18.8%	$400.0M-20.0%	$500.0M+1.0%	$495.0M+19.6%	$414.0M+40.4%	$295.0M+5.9%	$278.7M+36.2%	$204.6M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$310.4M+31.3%	$139.8M-28.1%	$225.6M-15.3%	$299.4M+17.6%	$236.4M-8.2%	$194.4M+2.3%	$266.2M-5.4%	$254.7M-3.6%
Depreciation & Amortization	$20.5M+5.3%	$20.6M+7.8%	$20.8M+6.9%	$20.3M+3.5%	$19.5M+2.2%	$19.1M-1.3%	$19.4M+0.5%	$19.6M+2.3%
Stock-Based Compensation	$5.4M0.0%	$5.5M+6.4%	N/A	$5.5M+25.0%	$5.4M+20.0%	$5.1M+8.8%	N/A	$4.4M+4.8%
Capital Expenditures	$27.8M+16.4%	$17.4M+0.9%	$41.5M+0.6%	$24.5M+14.3%	$23.9M+0.3%	$17.3M-0.8%	$41.3M+27.3%	$21.4M+2.2%
Free Cash Flow	$282.6M+33.0%	$122.4M-30.9%	$184.1M-18.2%	$274.9M+17.9%	$212.5M-9.1%	$177.2M+2.7%	$224.9M-9.7%	$233.2M-4.1%
Investing Cash Flow	-$1.9Mn/m	-$31.3Mn/m	-$40.4Mn/m	-$98.9Mn/m	-$47.6Mn/m	-$6.9Mn/m	-$51.1Mn/m	-$37.6Mn/m
Financing Cash Flow	-$317.7Mn/m	-$114.3Mn/m	-$192.1Mn/m	-$192.9Mn/m	-$186.0Mn/m	-$184.1Mn/m	-$223.7Mn/m	-$218.9Mn/m
Share Buybacks	$206.3M-5.7%	$206.3M-5.7%	$143.7M-32.4%	$218.7M+2.9%	$218.7M+2.9%	$218.7M+2.9%	$212.5M+20.7%	$212.5M-5.1%

Not reported in any period shown, so not listed: Dividends Paid.

MTD Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MTD quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	59.4%-0.7pp	60.1%+0.9pp	59.2%+0.3pp	58.9%+0.5pp	58.4%0.0pp	58.4%+0.5pp	57.9%+0.5pp	57.4%-0.4pp	57.8%+0.5pp	57.3%+0.9pp	56.4%+1.8pp	54.7%+0.8pp	53.9%+0.9pp	53.0%+0.3pp	52.8%
Net Margin	21.6%-0.7pp	22.3%+1.5pp	20.8%-1.4pp	22.3%+1.6pp	20.7%+1.1pp	19.5%+0.9pp	18.6%+1.2pp	17.5%+3.7pp	13.8%-1.5pp	15.3%+0.6pp	14.7%+1.1pp	13.6%+0.7pp	12.9%+0.5pp	12.4%+0.8pp	11.7%
Return on Equity	N/A	N/A	N/A	3519.1%+3070.6pp	448.6%+235.4pp	213.2%+79.9pp	133.3%+46.5pp	86.9%+18.2pp	68.7%-19.7pp	88.4%+27.6pp	60.8%+13.8pp	47.0%+14.3pp	32.7%-2.4pp	35.2%+0.7pp	34.5%
Return on Assets	23.4%-3.2pp	26.6%+3.1pp	23.5%-1.5pp	25.0%+1.9pp	23.1%+1.7pp	21.4%+1.3pp	20.1%+0.5pp	19.6%+4.8pp	14.8%-3.0pp	17.7%-0.3pp	18.0%+0.9pp	17.1%+2.9pp	14.2%-0.2pp	14.4%+1.6pp	12.7%
Current Ratio	1.14+0.1x	1.020.0x	1.04-0.2x	1.20+0.1x	1.11-0.2x	1.26-0.2x	1.470.0x	1.420.0x	1.46-0.1x	1.53+0.1x	1.42+0.2x	1.25-0.4x	1.62+0.1x	1.54-0.1x	1.67
Debt-to-Equity	N/A	N/A	N/A	76.98+67.8x	9.22+4.7x	4.54+1.6x	2.94+1.3x	1.67-0.1x	1.75-0.3x	2.01+1.0x	0.99+0.5x	0.470.0x	0.420.0x	0.42-0.2x	0.61
Liabilities-to-Equity	N/A	N/A	N/A	139.86+121.5x	18.41+9.5x	8.96+3.3x	5.63+2.2x	3.44-0.2x	3.66-0.3x	3.98+1.6x	2.38+0.6x	1.79+0.5x	1.30-0.1x	1.44-0.4x	1.82
Asset Turnover	1.08-0.1x	1.20+0.1x	1.130.0x	1.120.0x	1.120.0x	1.100.0x	1.080.0x	1.12+0.1x	1.07-0.1x	1.16-0.1x	1.220.0x	1.26+0.2x	1.10-0.1x	1.16+0.1x	1.09
FCF Margin	21.1%-1.2pp	22.3%-0.4pp	22.7%+3.9pp	18.8%-2.7pp	21.6%+1.1pp	20.5%+3.7pp	16.8%+2.4pp	14.4%+0.1pp	14.3%+0.8pp	13.4%-1.5pp	14.9%+1.7pp	13.3%+2.2pp	11.1%+1.2pp	9.9%+2.0pp	7.9%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	63.3%+4.3pp	58.7%-0.8pp	59.8%-1.4pp	59.2%-0.8pp	59.0%-0.8pp	59.5%+0.3pp	61.2%+2.2pp	60.0%+0.6pp
Net Margin	22.7%+2.1pp	17.9%-0.6pp	25.3%+1.2pp	21.1%-1.0pp	20.6%-2.8pp	18.5%-0.7pp	24.1%+4.4pp	22.2%+0.8pp
Return on Equity	1816.3%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	6.3%+0.4pp	4.6%-0.4pp	7.7%-0.1pp	6.2%-0.2pp	5.9%-0.9pp	5.1%-0.4pp	7.8%+2.3pp	6.4%+0.2pp
Current Ratio	1.120.0x	1.20+0.2x	1.14+0.1x	1.07+0.1x	1.12+0.2x	1.01-0.1x	1.020.0x	1.01-0.1x
Debt-to-Equity	159.45	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Liabilities-to-Equity	285.28	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Asset Turnover	0.280.0x	0.260.0x	0.300.0x	0.290.0x	0.290.0x	0.270.0x	0.320.0x	0.290.0x
FCF Margin	27.5%+5.9pp	12.9%-7.1pp	16.3%-5.2pp	26.7%+2.3pp	21.6%-3.1pp	20.1%+1.4pp	21.5%-5.1pp	24.4%-1.4pp

Not reported in any period shown, so not listed: Operating Margin.

Note: Shareholder equity is negative (-$23.6M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Mettler-Toledo International MTD	FY2025	$4.0B	$869.2M	21.6%	$33.5B	59/100
Labcorp Holdings Inc. LH	FY2025	$14.0B	$876.5M	6.3%	$26.7B	50/100
Agilent Technologies Inc. A	FY2025	$6.9B	$1.3B	18.8%	$48.8B	66/100
IQVIA Holdings Inc. IQV	FY2025	$16.3B	$1.4B	8.3%	$46.0B	49/100
Natera, Inc. NTRA	FY2025	$2.3B	-$208.2M	-9.0%	$58.2B	52/100
Quest Diagnostics Inc. DGX	FY2025	$11.0B	$992.0M	9.0%	$26.7B	54/100

Where Mettler-Toledo International Ranks

Frequently Asked Questions

What is Mettler-Toledo International's annual revenue?

Mettler-Toledo International (MTD) reported $4.0B in total revenue for fiscal year 2025. This represents a 4.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Mettler-Toledo International's revenue growing?

Mettler-Toledo International (MTD) revenue grew by 4.0% year-over-year, from $3.9B to $4.0B in fiscal year 2025.

Is Mettler-Toledo International profitable?

Yes, Mettler-Toledo International (MTD) reported a net income of $905.6M over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net income of $869.2M, with a net profit margin of 21.6%.

How much debt does Mettler-Toledo International have?

As of fiscal year 2025, Mettler-Toledo International (MTD) had $66.9M in cash and equivalents against $2.1B in long-term debt.

What is Mettler-Toledo International's gross margin?

Mettler-Toledo International (MTD) had a gross margin of 59.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Mettler-Toledo International's net profit margin?

Mettler-Toledo International (MTD) had a net profit margin of 21.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Mettler-Toledo International's free cash flow?

Mettler-Toledo International (MTD) generated $848.6M in free cash flow during fiscal year 2025. This represents a -1.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Mettler-Toledo International's operating cash flow?

Mettler-Toledo International (MTD) generated $955.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Mettler-Toledo International's total assets?

Mettler-Toledo International (MTD) had $3.7B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Mettler-Toledo International's capital expenditures?

Mettler-Toledo International (MTD) invested $107.1M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Mettler-Toledo International spend on research and development?

Mettler-Toledo International (MTD) invested $199.4M in research and development during fiscal year 2025.

Does Mettler-Toledo International buy back shares?

Yes, Mettler-Toledo International (MTD) spent $800.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Mettler-Toledo International have outstanding?

Mettler-Toledo International (MTD) had 20M shares outstanding as of fiscal year 2025.

What is Mettler-Toledo International's current ratio?

Mettler-Toledo International (MTD) had a current ratio of 1.14 as of fiscal year 2025, which is considered adequate.

What is Mettler-Toledo International's return on assets (ROA)?

Mettler-Toledo International (MTD) had a return on assets of 23.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Mettler-Toledo International's P/E ratio?

Mettler-Toledo International (MTD) trades at 36.9x earnings, its market capitalization divided by $905.6M net income, trailing 12 months to June 30, 2026. The market capitalization is $33.5B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Mettler-Toledo International's price-to-sales ratio?

Mettler-Toledo International (MTD) trades at 8.1x sales, its market capitalization divided by $4.1B revenue, trailing 12 months to June 30, 2026. The market capitalization is $33.5B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Why is Mettler-Toledo International's debt-to-equity ratio negative or not reported?

Mettler-Toledo International (MTD) has negative shareholder equity of -$23.6M as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Mettler-Toledo International's Piotroski F-Score?

Mettler-Toledo International (MTD) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Mettler-Toledo International's earnings high quality?

Mettler-Toledo International (MTD) has an earnings quality ratio of 1.10x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Mettler-Toledo International?

Mettler-Toledo International (MTD) scores 59 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.